Progyny Adds Depth to Executive Team
Jul 17, 2015
Karin Ajmani and Brian Dow join Progyny, Inc. to drive financial growth post-merger for Auxogyn and FertilityAuthority
New York, NY (PRWEB)July 15, 2015
Progyny, the first company to provide fertility patients with easy accessibility to high quality doctors, price transparency, financing and extraordinary clinical solutions, is proud to announce the addition of Karin Ajmani as President of Healthcare Services, and Brian Dow as Chief Financial Officer. Both Ms. Ajmani and Mr. Dow will play key roles in building and supporting Progyny’s expansion of services in the reproductive health space. “This is an extraordinary time for Progyny’s growth,” said Gina Bartasi, Chief Executive Officer. “We are excited to welcome Karin and Brian to the Progyny executive team. They bring decades of experience, energy and insight to our mission as we continue to innovate in the women’s health industry.”
Bringing a multitude of healthcare management expertise, Ms. Ajmani has joined as Progyny’s President of Healthcare Services. In her role, she is leading Progyny’s retail products and the development of Progyny’s newest product, IVFAdvantage PRO, a fertility benefit developed for large, self-insured employers. Prior to joining Progyny, Ms. Ajmani spent the past seven years as the Chief Executive Officer of US Imaging, a national radiology specialty health company serving health plans, self-insured employers and Taft-Hartley funds. Previously, Ms. Ajmani was the Chief Executive Officer of CarePlus Health Plan, a Medicaid managed care plan in New York, where she led the organization from inception through its sale in 2005 to the Amerigroup Corporation. Mr. Dow is a multi-faceted finance executive with over 20 years of experience specializing in building technology and life science companies. He joins Progyny following five years as Vice President and Principal Accounting Officer at Pacific Biosciences of California (PacBio), where he contributed to a successful initial public offering, the launch of its initial product and expansion into international markets in Europe and Asia. Prior to joining PacBio, Mr. Dow served as Chief Financial Officer of Northstar Neurosciences, a publicly traded medical device company. Mr. Dow will work out of Progyny’s Menlo Park office while Ms. Ajmani will work out of Progyny’s headquarters in New York City. Progyny's portfolio of products and services includes: Eeva ™ Test, the first and only non-invasive, FDA-cleared, time-lapse imaging system with a proprietary algorithm to consistently and objectively assess early embryo development milestones; IVFAdvantage , Progyny's no-restriction IVF package plan, offering bundled treatment plans with price transparency, scheduling assistance, financing and preferred appointment times at top clinics across the country; EggBanxx , the country’s leading network of elite fertility doctors specializing in vitrification, which is on a mission to empower young, professional women to take charge of their reproductive health by proactively preserving their fertility; and, FertilityAuthority.com, the country’s leading patient-matching technology platform serving the fertility industry through education, patient support, pricing transparency and financing. About The Company:
Progyny, the combined entity of Auxogyn, Inc. and Fertility Authority LLC, is the first company to provide fertility patients with easy accessibility to high quality doctors, price transparency, and financing, coupled with extraordinary clinical expertise and proprietary clinical solutions. Rooted in clinical excellence and serving as a champion for the consumer, the company is committed to helping ensure that patients control their fertility journey and achieve the best possible outcome. Progyny is privately held and its investors include Kleiner Perkins Caufield & Byers, TPG Biotech, SR One and Merck Serono Ventures. The company is headquartered in New York, NY, with operations in Menlo Park, CA. For more information, please visit http://www.progyny.com .